md-medicaldata

Authors

 

Tijana Kokovic¹, Nikola Batinić³, Viktorija Vučaj-Ćirilović², , Aleksandar Spasić¹, Dragan Nikolić³, Viktor Till<sup>1

1</sup>Centar za radiologiju, Univerzitetski klinički centar Vojvodine
²Institut za onkologiju Vojvodine, Centar za imidžing dojagnostiku
³Klinika za vaskularnu i endovaskularnu hirurgiju, Univerzitetski klinički centar Vojvodine

 

UDK: 616.13-089

The paper was received / Rad primljen: 21.01.2022.

Accepted / Rad prihvaćen: 15.03.2022.

 

Correspondence to:

Dr Tijana Koković
Centar za radiologiju
Univerzitetski klinički centar Vojvodine
Novi Sad
Hajduk Veljkova 1
e-mail: tijana.kokovic@icloud.com

 

 

Abstract

 

 

Introduction The clinical manifestation of peripheral arterial occlusive disease (PAOD) highly depends on the extent of atherosclerotic lesions. Trans-Atlantic Inter Society Consensus (TASC) II Classification of PAOD based on the prevalence and characteristics of atherosclerotic disease and their benefits for endovascular or open surgical therapy classifies patients in A-D stages. The aim of this study was to show the effect of revascularization after endovascular treatment on the iliac arteries depending on the stage of the disease according to the Leriche-Fontaine classification. Methods The study included patients with aortoilic occlusive disease (AIOD) treated with the endovascular revascularization during a period of six years, who were available for clinical examination (total of 87 patients). The study has prospective character. Results Endovascular procedure went as planned in 94,3% patients. The postprocedural course was without complications in 88,6% of patients. Preproceduraly majority of patients were in stadium IIb and III, while postproceduraly majority were in I and IIa. In 3 of patients amputation of treated lower extremity was performed. Control Duplex ultrasonography (DUS) showed in 86% of the patients the patentcy of stent. Conclusion Endovascular treatment of AIOD is a minimal-invasive therapeutic method, it is complementary to an open surgical revascularization method and in selected patients has a good revascularization effect, with acceptable mortality and morbidity.

 

 

 

Keywords:

peripheral arterial occlusive disease, iliac stents, TASC classification, endovascular treatment

 

 

 

Sažetak

 

Uvod Klinička manifestacija periferne arterijske okluzivne bolesti (PAOB) zavisi od proširenosti aterosklerotskih lezija. Trans-Atlantic Inter Society Consensus (TASC) II klasifikacija PAOB na osnovu proširenosti i karakteristika aterosklerotske bolesti determiniše vrstu terapije i svrstava pacijente u stadijume A do D. Cilj rada je prikazati efekat revaskularizacije nakon endovaskularnog tretmana na ilijačnim arterijama u zavisnosti od stadijuma bolesti prema Leriche-Fontaine klasifikaciji. MetodeStudijom su obuhvaćeni pacijenti sa aortoiličnom okluzivnom bolešću (AIOB) tretirani endovaskularnom revaskularizacijom u periodu od šest godina, dostupni za klinički pregled (ukupno 87 pacijenata). Studija je perspektivnog karaktera. Rezultati Endovaskularna procedura je protekla uredno kod 94.2% bolesnika. Postproceduralni tok je protekao uredno kod 87.3% bolesnika. Većina pacijenata je preproceduralno bila u stadijumu IIb i III, dok je postproceduralno većina bila u stadijumu I i IIa. Kod 3 pacijenta je postproceduralno načinjena amputacija tretiranog donjeg ekstremiteta. Kontrolna Duplex ultrasonografija (DUS) je pokazala je kod 83% bolesnika patentnost stenta. Zaključak Endovaskularni tretman AIOB je minimalno inavazivna terapijska metoda, komplemetarna otvorenoj hirurškoj revaskularizcionoj metodi i kod izabranih bolesnika ima dobar revaskularizacioni efekat, sa prihvatljivim mortalitetom i morbiditetom.

 

 

Ključne reči:

periferna arterijska okluzivna bolest, ilijačni stentovi, TASC klasifikacija, endovaskularni tretman

 

 

 

 

References:

1. Brown KN, Muco E, Gonzalez L. Leriche Syndrome. [Updated 2022 Feb 16]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538248/
2. Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S,Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation 1985;71(3):510-51.
3. Hiatt WR, Hoag S, Hamman RF. Effect of diagnostic criteria on theprevalence of peripheral arterial disease. The San Luis Valley DiabetesStudy. Circulation 1995;91(5):1472-9.
4. Cvetic V, Sagic D, Koncar I, et al. Endovascular treatment of different types of iliac occlusions-Results from an observational study. PLoS O ne. 2019;14(10).
5. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991;20(2):384-92.
6. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, et al. Meta-analysis:glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004;141(6):421-31.
7. ADA Peripheral arterial disease in people with diabetes. Diabetes Care 2003;26(12):3333-41.
8. O’Hare AM, Vittinghoff E, Hsia J, Shlipak MG. Renal insufficiency and the risk of lower extremity peripheral arterial disease: results from the Heart and Estrogen/Progestin Replacement Study (HERS). J Am Soc Nephrol 2004;15(4):1046-51.
9. Serefli D, Saydam O, Engin AY, Atay M. Midterm results of kissing stent reconstruction of the aortoiliac bifurcation. Ann Surg Treat Res. 2021 Oct;101(4):247-255. 
10. . Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC). Eur J Vasc Endovasc Surg 2000; 19(Suppl A):Si-xxviii. S1-250.
11. TASC. Management of Peripheral Arterial Disease (PAD) TransAtlantic Intersociety Consensus (TASC). J Vasc Surg 2000;31(1 part 2):S1-287.
12. TASC. Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC). Int Angiol 2000;19(1 Suppl.1):I-XXIV. 1-304.
13. Clement DL, Boccalon H, Dormandy J, Durand-Zaleski I, Fowkes G, Brown T. A clinical approach to the management of the patient with coronary (Co) and/or carotid (Ca) artery disease who presents with leg ischaemia (Lis). Int Angiol 2000;19(2):97-125.
14. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extermity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery,Society for Cardiovascular Angiography and Interverntions, Society for Vascular Medicine and Biology, Society of Interventional Raidology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management ofPatients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing;TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 2006;47:1239-312.
15. Minici R, Ammendola M, Talarico M, Luposella M, Minici M, Ciranni S, Guzzardi G, Laganà D. Endovascular recanalization of chronic total occlusions of the native superficial femoral artery after failed femoropopliteal bypass in patients with critical limb ischemia. CVIR Endovasc. 2021 Sep 7;4(1):68.
16. Leville CD, Kashyap VS, Clair DG, et al. Endovascular management of iliac artery occlusions: extending treatment to TransAtlantic Inter-Society Consensus class C and D patients. J Vasc Surg. 2006;43:32–39.
17. Sixt S, Alawied AK, Rastan A, et al. Acute and long-term outcome of endovascular therapy for aortoiliac occlusive lesions stratified according to the TASC classification: a single-center experience. J Endovasc Ther. 2008;15:408–416.
    

PDFKoković T. et al MD-Medical Data 2022;14(1-2): 025-029